Brean Murray initiates coverage of Seattle Genetics, Inc. (Nasdaq: SGEN) with a Hold rating.

Brean analyst says, "We view Seattle ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE